Metastatic gastrointestinal stromal tumor with an Exon 11 c-Kit mutation responding to the tyrosine kinase inhibitor imatinib

被引：4
|
作者：
Cho, H
Kobayashi, O
Tsuburaya, A
Sugiyama, Y
Sairenji, M
Motohashi, H
Yoshida, T
Miyagi, Y
Imada, T
机构：
[1] Yokohama City Univ, Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Kanagawa Canc Ctr, Div Pathol, Lab Mol Diagnost, Yokohama, Kanagawa 232, Japan
[3] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan
来源：
DIGESTIVE SURGERY | 2004年 / 21卷 / 01期
关键词：
gastrointestinal stromal tumor; imatinib; C- kit mutation;
D O I：
10.1159/000076756
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：74 / 77
页数：4
相关论文
共 50 条
  • [21] Understanding Rechallenge and Resistance in the Tyrosine Kinase Inhibitor Era Imatinib in Gastrointestinal Stromal Tumor
    Agulnik, Mark
    Giel, Jennifer L.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (04): : 417 - 422
  • [22] Familial Gastrointestinal Stromal Tumor Syndrome: Report of 2 Cases With KIT Exon 11 Mutation
    Jones, Derek H.
    Caracciolo, Jamie T.
    Hodul, Pamela J.
    Strosberg, Jonathan R.
    Coppola, Domenico
    Bui, Marilyn M.
    CANCER CONTROL, 2015, 22 (01) : 102 - 108
  • [23] Mutation of the KIT Gene, excluding Exon 11, in Gastrointestinal Stromal Tumors
    Liu Qiu Yu
    Kong Ling Fei
    Xu Zi Gung
    Li Zhen
    Xue Huan Zhou
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2020, 33 (05) : 369 - 373
  • [24] Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours
    Pang, N. K. B.
    Chin, S. Y.
    Nga, M. E.
    Chang, A. R.
    Ismail, T. -M.
    Omar, S. -S.
    Charlton, A.
    Salto-Tellez, M.
    CYTOPATHOLOGY, 2009, 20 (05) : 297 - 303
  • [25] Mutation of the KIT Gene, excluding Exon 11, in Gastrointestinal Stromal Tumors
    LIU Qiu Yu
    KONG Ling Fei
    XU Zi Gung
    LI Zhen
    XUE Huan Zhou
    Biomedical and Environmental Sciences, 2020, 33 (05) : 369 - 373
  • [26] A PHASE II STUDY OF IMATINIB MESYLATE AS ADJUVANT TREATMENT FOR CURATIVELY RESECTED HIGH-RISK LOCALIZED GASTROINTESTINAL STROMAL TUMORS WITH C-KIT EXON 11 MUTATION
    Kang, Y.
    Kang, B. W.
    Ryu, M.
    Im, S.
    Park, S. R.
    Kang, W. K.
    Kim, T. W.
    Oh, D.
    Jung, K. H.
    Lee, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 169 - 169
  • [27] Familial gastrointestinal stromal tumor with hyperpigmentation:: Association with a germline mutation of the c-kit gene
    Maeyama, H
    Hidaka, E
    Ota, H
    Minami, S
    Kajiyama, M
    Kuraishi, A
    Mori, H
    Matsuda, Y
    Wada, S
    Sodeyama, H
    Nakata, S
    Kawamura, N
    Hata, S
    Watanabe, M
    Iijima, Y
    Katsuyama, T
    GASTROENTEROLOGY, 2001, 120 (01) : 210 - 215
  • [28] Analysis of mutation and expression of c-kit and PDGFR-α gene in gastrointestinal stromal tumor
    Zheng, Song
    Chen, Li-Rong
    Wang, Hai-Jun
    Chen, Shui-Zhen
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2285 - 2290
  • [29] Multiple gastrointestinal stromal tumors with a germline c-kit mutation
    Kim, HJ
    Lim, SJ
    Park, K
    Yuh, YJ
    Jang, SJ
    Choi, J
    PATHOLOGY INTERNATIONAL, 2005, 55 (10) : 655 - 659
  • [30] Analysis of C-Kit and Pdgfrα Gene Mutation in Gastrointestinal Stromal Tumor of the Small Intestine
    Yamada, Masayoshi
    Shiroeda, Hisakazu
    Ozaki, Kazuaki
    Tsuchishima, Mutsumi
    Tsutsumi, Mikihiro
    Arisawa, Tomiyasu
    GASTROENTEROLOGY, 2009, 136 (05) : A761 - A761
12345